Journal of Diabetes and Its Complications
Volume 21, Issue 3 , Pages 149-157 , May 2007

Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction: Arterial dysfunction in obesity and diabetes

  • William I. Sivitz

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Internal Medicine, Iowa City Veterans Affairs Medical Center and the University of Iowa, Iowa City, IA 52242, USA
    • University of Iowa General Clinical Research Center, Iowa City, IA, USA
    • Corresponding Author InformationCorresponding author. Division of Endocrinology, Department of Internal Medicine, University of Iowa Health Care, 200 Hawkins Drive, Iowa City, IA 52242, USA. Tel.: +1 319 353 7710; fax: +1 319 353 7850.
    • ,
  • Sheila M. Wayson

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Internal Medicine, Iowa City Veterans Affairs Medical Center and the University of Iowa, Iowa City, IA 52242, USA
    • University of Iowa General Clinical Research Center, Iowa City, IA, USA
    • ,
  • Margaret L. Bayless

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Internal Medicine, Iowa City Veterans Affairs Medical Center and the University of Iowa, Iowa City, IA 52242, USA
    • University of Iowa General Clinical Research Center, Iowa City, IA, USA
    • ,
  • Christine A. Sinkey

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, Iowa City Veterans Affairs Medical Center and the University of Iowa, Iowa City, IA 52242, USA
    • University of Iowa General Clinical Research Center, Iowa City, IA, USA
    • ,
  • William G. Haynes

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, Iowa City Veterans Affairs Medical Center and the University of Iowa, Iowa City, IA 52242, USA
    • University of Iowa General Clinical Research Center, Iowa City, IA, USA

Received 7 October 2005 ,Revised 7 December 2005 ,Accepted 29 December 2005.

References 

  1. Al Suwaidi J, Higano ST, Holmes DR, Lennon R, Lerman A. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. Journal of the American College of Cardiology. 2001;37:1523–1528
  2. American Diabetes Association . Standards of medical care in diabetes. Diabetes Care. 2004;27:S15–S35
  3. Arcaro G, Zamboni M, Rossi L, Turcato E, Covi G, Armellini F, et al. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. International Journal of Obesity & Related Metabolic Disorders: Journal of the International Association for the Study of Obesity. 1999;23:936–942
  4. Bergholm R, Tiikkainen M, Vehkavaara S, Tamminen M, Teramo K, Rissanen A, et al. Lowering of LDL cholesterol rather than moderate weight loss improves endothelium-dependent vasodilatation in obese women with previous gestational diabetes. Diabetes Care. 2003;26:1667–1672
  5. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocrine Reviews. 1985;6:45–86
  6. Brook RD, Bard RL, Rubenfire M, Ridker PM, Rajagopalan S. Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. American Journal of Cardiology. 2001;88:1264–1269
  7. Coates PA, Luzio SD, Brunel P, Owens DR. Comparison of estimates of insulin sensitivity from minimal model analysis of the insulin-modified frequently sampled intravenous glucose tolerance test and the isoglycemic hyperinsulinemic clamp in subjects with NIDDM. Diabetes. 1995;44:631–635
  8. Di Carli MF, Janisse J, Grunberger G, Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. Journal of the American College of Cardiology. 2003;41:1387–1393
  9. Et-Taouil K, Safar M, Plante GE. Mechanisms and consequences of large artery rigidity. Canadian Journal of Physiology & Pharmacology. 2003;81:205–211
  10. Goodfellow J, Ramsey MW, Luddington LA, Jones CJ, Coates PA, Dunstan F, et al. Endothelium and inelastic arteries: An early marker of vascular dysfunction in non-insulin dependent diabetes. British Medical Journal. 1996;312:744–745
  11. Hashimoto M, Akishita M, Eto M, Kozaki K, Ako J, Sugimoto N, et al. The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation. International Journal of Obesity & Related Metabolic Disorders: Journal of the International Association for the Study of Obesity. 1998;22:477–484
  12. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Chayama K, Oshima T. Effect of obesity on endothelium-dependent, nitric oxide-mediated vasodilation in normotensive individuals and patients with essential hypertension. American Journal of Hypertension. 2001;14:1038–1045
  13. Hogikyan RV, Galecki AT, Halter JB, Supiano MA. Heightened norepinephrine-mediated vasoconstriction in type 2 diabetes. Metabolism: Clinical and Experimental. 1999;48:1536–1541
  14. Hogikyan RV, Galecki AT, Pitt B, Halter JB, Greene DA, Supiano MA. Specific impairment of endothelium-dependent vasodilation in subjects with type 2 diabetes independent of obesity. Journal of Clinical Endocrinology and Metabolism. 1998;83:1946–1952
  15. Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation. 1999;100:1161–1168
  16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  17. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992;35:771–776
  18. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes. 1993;42:1017–1025
  19. Pitkanen OP, Nuutila P, Raitakari OT, Ronnemaa T, Koskinen PJ, Iida H, et al. Coronary flow reserve is reduced in young men with IDDM. Diabetes. 1998;47:248–254
  20. Putz DGWS, Bar RS, Haynes WG, Sivitz WI. Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy. Metabolism Clinical & Experimental. 2004;53:1454–1461
  21. Sivitz WI, Wayson SM, Bayless ML, Larson LF, Sinkey C, Bar RS, et al. Leptin and body fat in type 2 diabetes and monodrug therapy. Journal of Clinical Endocrinology Metabolism. 2003;88:1543–1553
  22. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. Journal of Clinical Investigation. 1996;97:2601–2610
  23. Steinberg HO, Paradisi G, Cronin J, Crowde K, Hempfling A, Hook G, et al. Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation. 2000;101:2040–2046
  24. Tack CJ, Ong MK, Lutterman JA, Smits P. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone. Diabetologia. 1998;41:569–576
  25. Watts GF, O'Brien SF, Silvester W, Millar JA. Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: Role of dyslipidaemia. Clinical Science. 1996;91:567–573
  26. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. Journal of the American College of Cardiology. 1996;27:567–574
  27. Yokoyama I, Momomura S, Ohtake T, Yonekura K, Nishikawa J, Sasaki Y, et al. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. Journal of the American College of Cardiology. 1997;30:1472–1477

☆ Supported by the Department of Veterans Affairs Office of Research and Development, the Juvenile Diabetes Foundation International, grant DK25295 from the NIH, and by grant M01-RR00059, National Center for Research Resources, General Clinical Research Centers Program, NIH.

PII: S1056-8727(06)00004-3

doi: 10.1016/j.jdiacomp.2005.12.003

Journal of Diabetes and Its Complications
Volume 21, Issue 3 , Pages 149-157 , May 2007

Article Tools

* Image Usage & Resolution